What market-cap range did most 10x stocks have at the last possible entry point?
About 70% were under $500 million and 83% were under $1 billion; only 2% were above $10 billion.
Video Summary
70% of stocks that 10x'd within five years had market caps under $500M at the last investable entry; only 2% exceeded $10B.
Median time to a 10x was 35 months; only 16% did it within one year.
Faster rises carried bigger crashes: stocks that 10x in one year had a median 90% drop within three years.
Traditional fundamentals (profitability, revenue growth, ROE) rarely predicted 10x outcomes; 33% were profitable at the start.
72% of 10x stocks had low debt (debt-to-equity < 1), making low leverage a recurring trait of big winners.
About 70% were under $500 million and 83% were under $1 billion; only 2% were above $10 billion.
The median time was 35 months (just under 3 years); only 16% achieved 10x within 12 months.
No — stocks that 10x within a year had a median decline of 90% within three years; faster rises correlated with larger subsequent drawdowns.
Low leverage: 72% had debt-to-equity below 1. Profitability, revenue growth, and ROE were not reliable predictors.
Biotechnology accounted for about 15% of 10x stocks and healthcare roughly 25% overall, reflecting sector-specific catalysts like regulatory approvals.
After market corrections or downturns — many big winners ran following significant market drawdowns.
"I tracked 15,000 stocks over 20 years to find those rare stocks at 10 times in price within just a 5-year window."
The analysis involved tracking a vast number of stocks over two decades to identify those that achieved a remarkable 10x increase in value within a five-year period.
Initial assumptions about the randomness of such stocks were challenged by findings that indicated identifiable patterns in their performance.
"70% had a valuation under $500 million. Only 2% were above $10 billion."
A substantial majority, around 70%, of the identified stocks that achieved a 10x return had market valuations of less than $500 million, suggesting that most high-growth opportunities emerge from smaller companies.
Only a minor fraction, about 2%, of these stocks surpassed a market cap of $10 billion, illustrating the rarity of large-cap stocks experiencing such rapid growth within a short timeframe.
"A 10x gain in 5 years is extremely rare with large-cap stocks."
Achieving a 10x gain in five years is significantly uncommon for large-cap stocks, as exemplified by Microsoft's decade-long journey to reach similar heights.
The analysis indicated that most stocks took an average of 35 months to reach their peak, with only 16% achieving a 10x return within just one year.
"Stocks which 10x'ed within a year had a median drop of 90% from their peak by just 3 years later."
Stocks that exponentially increased in value within a short period tended to experience substantial declines shortly thereafter, with those doubling in a year seeing an average drop of 90% in the following three years.
The quicker the rise, the higher the chances of a significant subsequent drop, emphasizing the inherent volatility and risk associated with such rapid growth.
"72% of these stocks which went on to 10x had low debt."
Despite conventional wisdom suggesting that profitable and fast-growing companies are more likely to achieve 10x returns, only a third of these stocks were profitable at the beginning of their growth phases.
Interestingly, a key indicator for many successful stocks was maintaining low debt levels, allowing them flexibility to invest in growth without the financial constraints imposed by high leverage.
"Biotechnology represents 15% of all 10x stocks just on its own."
The analysis revealed that the biotechnology industry produced the highest number of 10x stocks, accounting for 15%, with healthcare as a whole representing 25%.
The unique characteristics of biotech firms, especially the potential for rapid growth post-FDA approval, position them as prime candidates for achieving significant returns in value.
"Periods of market downturns create the best opportunities for explosive stock growth."
The video highlights significant market corrections, such as the 2016 slowdown, which affected stocks significantly, with declines ranging from 13% to 15%.
The analysis draws attention to how stocks that eventually achieve a tenfold increase often experience downturns before their growth surge.
Historical examples include Under Armour, Domino's Pizza, and Lululemon, which saw massive growth following the 2008-2009 market downturn. Similarly, Nvidia, Shopify, and Etsy rose dramatically after the 2016 downturn, and stocks like Broadcom, Neo, and Arista Networks had their runs after the market decline in 2020.
The median drawdowns of stocks that later achieved a tenfold increase were notably profound, averaging declines of 30% to 40% below their 52-week highs.
This correlation illustrates a pattern of explosive growth following significant declines, reinforcing the idea that the wider market does influence these tenbagger stocks.
"Be fearful when others are greedy and greedy when others are fearful."
The video discusses how investment opportunities are often most abundant when market sentiment is bleak.
The analysis indicated that even the most volatile and explosive stocks follow the trend of being undervalued during market fears, which supports Buffett's famous investment strategy.
This revelation encourages investors to consider increasing their stakes in high-potential stocks during bearish market conditions rather than avoiding them out of fear.
"The best opportunities arise in the darkest times."
Although the analysis highlights the challenges of finding small stocks that might achieve substantial growth, it emphasizes the importance of identifying firms with resilience.
The speaker expresses a desire to explore methods for identifying stocks that are likely to weather market declines and prosper as conditions improve.
Viewers are encouraged to watch an additional video that will provide insights into differentiating stocks that recover successfully from those that do not after a downturn.